Hippocampal neuronal hyperactivity

Hippocampal neuronal hyperactivity refers to an abnormally increased level of electrical activity among neurons within the hippocampus. This is not a single molecular target but rather a circuit-level or physiological phenomenon that can arise from various underlying molecular changes. It has been implicated in several neurological and psychiatric conditions: • In Alzheimer’s disease, hippocampal neuronal hyperactivity is associated with early accumulation and spread of tau and amyloid-beta proteins before overt memory deficits appear. Imaging studies have shown that this state can be detected even in asymptomatic individuals at risk for AD, such as APOE4 carriers. • In schizophrenia, excessive activation within the hippocampus—particularly its output regions—can drive abnormal dopamine release via downstream circuits like the ventral tegmental area (VTA), contributing to psychotic symptoms through aberrant salience assignment. • In epilepsy models and after traumatic brain injury, increased excitatory signaling in the hippocampus activates neural stem cells but may also lead to excitotoxicity and neuroinflammation. • The phenomenon also plays roles in mood regulation, behavioral inhibition, spatial navigation/memory formation, stress response modulation via HPA axis feedback, as well as being linked with depression/anxiety when dysregulated. While drugs such as levetiracetam or NAC are being explored for their ability to dampen this pathological overactivation by targeting upstream neurotransmitter systems (notably glutamatergic transmission), “hippocampal neuronal hyperactivity” itself is not a discrete druggable molecule or receptor but rather an emergent property of network dysfunction involving multiple cell types and signaling pathways.

Other names

Hippocampal hyperactivityNeuronal hyperexcitation in the hippocampusHyperactive hippocampal neurons

Reduction of excess glutamatergic activity to decrease circuit-level hyperactivity